Found 8 matching trials
Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection
PHASE3The purpose of this study is to evaluate the long term safety and tolerabil...
Location
Multiple Locations
Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.
PHASE2This is a study to determine the safety and tolerability of 28 days of dail...
Location
Multiple Locations
A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants
PHASE1The primary purpose of this study is to determine the intra and extra pulmo...
Location
Multiple Locations
Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections
PHASE3A major factor in the respiratory health of Cystic Fibrosis (CF) participan...
Location
Multiple Locations
Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase
PHASE2A major factor in the respiratory health of cystic fibrosis (CF) patients i...
Location
Multiple Locations
Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa
PHASE1This is a study to determine the safety and tolerability of 28 days of dail...
Location
Multiple Locations
Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease
PHASE2The proposed study will assess the efficacy, safety and tolerability of onc...
Location
Oregon Health & Science University
Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)
PHASE1A major factor in the respiratory health of cystic fibrosis (CF) subjects i...
Location
Multiple Locations